Cardiac Toxicities
Leadership
Chair
Susan Dent, MD
United States
Vice-Chair
TBD
Cardiac Toxicities is a subgroup of the Emerging Toxicities Study Group
Mission and Goals
Emerging anticancer agents often have narrow therapeutic windows and can cause significant organ damage. The Cardiac Toxicities Subgroup will focus on the development of research studies, guidelines, and educational initiatives to enhance patient safety and longer term outcomes for the use of these emerging agents, with the aim of providing leadership in continual improvement of supportive care and treatment outcomes.
How to Join
To join a subgroup, you must be a MASCC member and a member of the parent study group. The parent study group of the Cardiac Toxicities Subgroup is the Emerging Toxicities Study Group.
Guidelines
Evidence-based clinical practice guidelines created by the Cardiac Toxicities Subgroup